The School's Dr Katherine Dunn recently chaired the international research meeting Nucleic Acids in MEdicine (NAME) 2019 at Murchison House, exploring possibilities for collaboration between European academics and industry partners at the interface between engineering and life sciences.
Dr Katherine Dunn of the Institute for Bioengineering, has been awarded funding to establish a European consortium that will focus on the development of new devices and systems to improve the understanding, diagnosis and treatment of disease, using engineered biological molecules and nanotechnology.
